Cargando…
Sexual Dysfunction in Menopausal Women
INTRODUCTION: Hormone-related changes in menopause may negatively affect sexual function. AIM: The primary aim of this study was to evaluate sexual functioning in Polish women with the Female Sexual Function Index (FSFI). The secondary aim was to evaluate the major factors affecting sexual functions...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963159/ https://www.ncbi.nlm.nih.gov/pubmed/31371259 http://dx.doi.org/10.1016/j.esxm.2019.06.010 |
_version_ | 1783488222133747712 |
---|---|
author | Dąbrowska-Galas, Magdalena Dąbrowska, Jolanta Michalski, Bogdan |
author_facet | Dąbrowska-Galas, Magdalena Dąbrowska, Jolanta Michalski, Bogdan |
author_sort | Dąbrowska-Galas, Magdalena |
collection | PubMed |
description | INTRODUCTION: Hormone-related changes in menopause may negatively affect sexual function. AIM: The primary aim of this study was to evaluate sexual functioning in Polish women with the Female Sexual Function Index (FSFI). The secondary aim was to evaluate the major factors affecting sexual functions in middle-aged Polish women. METHODS: The Menopause Rating Scale was used to assess the menopausal symptoms. The Polish translation of the FSFI was used to assess sexual function. OUTCOMES: 69.73% of respondents had sexual dysfunction according to FSFI (FSFI score ≤ 26.55). RESULTS: 80.61% of women experienced menopausal symptoms during the 4-week period of study. Psychological and urogenital symptoms were the most frequently reported among all the women enrolled in the study (78.23% and 77.21%). Sexual problems were observed in women who did not use hormone therapy (β = 0.09, t = −1.97, P = .048) and showed no somatic symptoms (β = 0.03, t = 2.95, P = .002). CLINICAL IMPLICATIONS: It is important for health care providers to ask women about this problem and understand the factors that may influence sexual problems in menopause. STRENGTHS & LIMITATIONS: A validated survey tool was used. The limitation was selection of participants in the clinical setting and sample population size. CONCLUSION: Sexual problems were much more common in women who did not use hormone therapy and showed no somatic symptoms. Dąbrowska-Galas M, Dąbrowska J, Michalski B. Prevalence and Associated Risk Factors of Sexual Problems Among Polish Middle-Aged Women. Sex Med 2019;7:472–479. |
format | Online Article Text |
id | pubmed-6963159 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-69631592020-01-22 Sexual Dysfunction in Menopausal Women Dąbrowska-Galas, Magdalena Dąbrowska, Jolanta Michalski, Bogdan Sex Med Women's Sexual Health INTRODUCTION: Hormone-related changes in menopause may negatively affect sexual function. AIM: The primary aim of this study was to evaluate sexual functioning in Polish women with the Female Sexual Function Index (FSFI). The secondary aim was to evaluate the major factors affecting sexual functions in middle-aged Polish women. METHODS: The Menopause Rating Scale was used to assess the menopausal symptoms. The Polish translation of the FSFI was used to assess sexual function. OUTCOMES: 69.73% of respondents had sexual dysfunction according to FSFI (FSFI score ≤ 26.55). RESULTS: 80.61% of women experienced menopausal symptoms during the 4-week period of study. Psychological and urogenital symptoms were the most frequently reported among all the women enrolled in the study (78.23% and 77.21%). Sexual problems were observed in women who did not use hormone therapy (β = 0.09, t = −1.97, P = .048) and showed no somatic symptoms (β = 0.03, t = 2.95, P = .002). CLINICAL IMPLICATIONS: It is important for health care providers to ask women about this problem and understand the factors that may influence sexual problems in menopause. STRENGTHS & LIMITATIONS: A validated survey tool was used. The limitation was selection of participants in the clinical setting and sample population size. CONCLUSION: Sexual problems were much more common in women who did not use hormone therapy and showed no somatic symptoms. Dąbrowska-Galas M, Dąbrowska J, Michalski B. Prevalence and Associated Risk Factors of Sexual Problems Among Polish Middle-Aged Women. Sex Med 2019;7:472–479. Elsevier 2019-07-29 /pmc/articles/PMC6963159/ /pubmed/31371259 http://dx.doi.org/10.1016/j.esxm.2019.06.010 Text en © 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Women's Sexual Health Dąbrowska-Galas, Magdalena Dąbrowska, Jolanta Michalski, Bogdan Sexual Dysfunction in Menopausal Women |
title | Sexual Dysfunction in Menopausal Women |
title_full | Sexual Dysfunction in Menopausal Women |
title_fullStr | Sexual Dysfunction in Menopausal Women |
title_full_unstemmed | Sexual Dysfunction in Menopausal Women |
title_short | Sexual Dysfunction in Menopausal Women |
title_sort | sexual dysfunction in menopausal women |
topic | Women's Sexual Health |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6963159/ https://www.ncbi.nlm.nih.gov/pubmed/31371259 http://dx.doi.org/10.1016/j.esxm.2019.06.010 |
work_keys_str_mv | AT dabrowskagalasmagdalena sexualdysfunctioninmenopausalwomen AT dabrowskajolanta sexualdysfunctioninmenopausalwomen AT michalskibogdan sexualdysfunctioninmenopausalwomen |